Lattice forms American Clinical Research Services and acquires Catalina Research Institute

McGuireWoods LLP represented Latticework in the transaction.

  • CRI focuses on high complexity trials across non-alcoholic steatohepatitis, non-alcoholic fatty liver disease, diabetes and other metabolic diseases as well as central nervous system
  • Founded in 2015, Latticework invests in lower-middle market healthcare companies
  • Currently, the firm has over $335 million in assets under management

Latticework Capital Management has formed American Clinical Research Services Holdings, which acquired Montclair, California-based based Catalina Research Institute, a clinical trials center. No financial terms were disclosed.

CRI focuses on high complexity trials across non-alcoholic steatohepatitis, non-alcoholic fatty liver disease, diabetes and other metabolic diseases as well as central nervous system.

CRI was founded by Joe and Victoria Calleros.

“CRI has mastered the management of complex clinical trials and we’re confident in our ability to build a scalable network of owned and operated sites collectively benefitting from sharing best practices, standard operating procedures, budgeting and contracting processes,” said Kyle Bradford, managing partner and co-founder of LCM, in a statement. “With record amounts of capital being raised by pharma and biotech companies, CRI’s growth, supported by ACRS, will be a model for the future of SMOs working to expand their clinical trial pipelines and increase revenue.”

LCM has completed more than 75 transactions across a diverse array of healthcare subsectors.

McGuireWoods LLP represented Latticework in the transaction.

Founded in 2015, Latticework invests in lower-middle market healthcare companies. Currently, the firm has over $335 million in assets under management.